Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri +12 more
wiley +1 more source
Neutrophil-to-Lymphocyte Ratio as a Biomarker for Postoperative Complications in Crohn's Disease. [PDF]
Kawamoto M +8 more
europepmc +1 more source
Abstract Objective This study was undertaken to evaluate whether synaptic vesicle protein 2A (SV2A) expression on peripheral immune cells predicts treatment response to levetiracetam in epilepsy. Methods High‐dimensional flow cytometry was used to prospectively assess SV2A expression on immune cells from levetiracetam responders, nonresponders, and ...
Johannes Lang +4 more
wiley +1 more source
Neutrophil-to-lymphocyte ratio as a predictor of mortality in patients with acute kidney injury: a systematic review and meta-analysis. [PDF]
Guedes IHL +5 more
europepmc +1 more source
The multiple hit model of infantile and epileptic spasms: The 2025 update
Abstract Objective Infantile and epileptic spasms syndrome (IESS) is a developmental and epileptic encephalopathy manifesting with epileptic spasms and poor neurodevelopmental outcomes. There is an urgent need for the development of more effective and tolerated therapies.
Aristea S. Galanopoulou +6 more
wiley +1 more source
The supplementary value of the neutrophil-to-lymphocyte ratio in the diagnosis of rheumatoid arthritis. [PDF]
Yang X.
europepmc +1 more source
The neutrophil-to-lymphocyte ratio in rheumatoid arthritis: The dual perspectives from literature and clinic. [PDF]
Li Y +5 more
europepmc +1 more source
Generation of effector cells from T cell subsets [PDF]
Koszinowski, Ulrich H., Simon, M. M.
core
Neutrophil-to-Lymphocyte Ratio as an Independent Predictor of Adverse Short-Term Functional Outcomes After Reperfusion Therapy in Acute Ischemic Stroke. [PDF]
Li JY +9 more
europepmc +1 more source

